{"meta":{"query_hash":"5e7fe4b0bbff","filters":{"venue":"Biologics in Therapy"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5e7fe4b0bbff","api":"https://metacan.xera.ac/api/v1/cohort?venue=Biologics+in+Therapy"},"results":[{"id":"W2077733407","doi":"10.1007/s13554-011-0009-3","title":"New Frontiers in Subcutaneous Immunoglobulin Treatment","year":2011,"lang":"en","type":"review","venue":"Biologics in Therapy","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Multifocal motor neuropathy; Mismatch negativity; Intravenous Immunoglobulin Therapy; Tolerability; Adverse effect; Antibody; Internal medicine; Immunoglobulin G; Gastroenterology; Immunology","score_opus":0.0942810381799841,"score_gpt":0.3355394829311385,"score_spread":0.2412584447511544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077733407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004976967,0.7093261,0.012364425,0.19687426,0.019983375,0.000104008526,0.00025472022,0.00039644947,0.055719722],"genre_scores_gemma":[0.056589883,0.74099535,0.019442925,0.07964628,0.06063413,0.00028236417,0.0006846785,0.0002570227,0.041467313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982663,0.00054276054,0.00015775181,0.00025407784,0.0005333243,0.00024579684],"domain_scores_gemma":[0.9942569,0.0027691575,0.0004223869,0.00039490024,0.0010769797,0.0010796069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048568277,0.0006916661,0.0009176833,0.0011568911,0.00045275028,0.0028334148,0.0014281527,0.0040272283,0.023143474],"category_scores_gemma":[0.004492929,0.00027410532,0.0010215577,0.0009508233,0.0026651805,0.005286805,0.0012278699,0.00694178,0.00653588],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031906803,0.0003869629,0.0013162524,0.0018912315,0.000044789336,0.00069037435,0.00018015502,0.00034213738,0.0020344981,0.04841781,0.114395194,0.8299815],"study_design_scores_gemma":[0.00010907366,0.00049372227,0.001140053,0.0012717033,0.000024282865,0.0023214954,0.00018816571,0.00046584208,0.00052296126,0.024098527,0.9693391,0.000025078403],"about_ca_topic_score_codex":0.0006712046,"about_ca_topic_score_gemma":0.0011414412,"teacher_disagreement_score":0.023143474,"about_ca_system_score_codex":0.0015814247,"about_ca_system_score_gemma":0.0024104489,"threshold_uncertainty_score":0.07742262},"labels":[],"label_agreement":null}]}